bioidentical progesterone

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• amenorrhea [Insufficient Evidence]
• benzodiazepine withdrawal [Insufficient Evidence]
• cardiovascular disease [Insufficient Evidence]
• cocaine dependence [Insufficient Evidence]
• endometrial hyperplasia [Insufficient Evidence]
• fibrocystic breast disease [Insufficient Evidence]
• hormone replacement therapy [Insufficient Evidence]
• infertility [Insufficient Evidence]
• mastalgia [Insufficient Evidence]
• menopausal symptoms [Insufficient Evidence]
• miscarriage prevention [Insufficient Evidence]
• osteoporosis [Insufficient Evidence]
• postpartum depression [Insufficient Evidence]
• preterm labor prevention [Insufficient Evidence]
• premenstrual syndrome [Insufficient Evidence]
• traumatic brain injury [Insufficient Evidence]
• uterine fibroids [Insufficient Evidence]
• vulval lichen sclerosus [Insufficient Evidence]

Reported Doses

Safety/efficacy may not be established; reported doses may be derived from limited or potentially inadequate studies with variable regimens, multi-ingredient products, or where concentration of active ingredients may vary widely

Special Note

[formulation clarification]

Info: for FDA-approved Rx products see progesterone micronized, progesterone vaginal, or other injectable forms; all other preparations are not FDA-approved

Effectiveness Ratings

[see Herb & Supplement Effectiveness Rating Definitions table]

menopausal symptoms

[Insufficient Evidence]

Dose: apply 20 mg cream topically qd